// App-Quantinova.ai

TCTAP A-002 : Paclitaxel-coated Balloon Versus Paclitaxel-eluting Stent for the Treatment of Diffuse DES In-stent Restenotic Lesions: A Substudy of PEPCAD China ISR Trial

Researchers

Presenter

  • Ye-lin Zhao

Principal Investigators

  • Bo Xu

  • Jie Qian

  • Jian-an Wang

  • Shao-Liang Chen

  • Yue-jing Yang

  • Jun-bo Ge

  • Run-Lin Gao

Medical Centers

  • Fudan University Cancer Hospital, Shanghai, China

  • Nanjing First Hospital, Nanjing Medical University, Nanjing, China

  • Fu Wai Hospital, National Center for Cardiovascular Diseases, China, Beijing, China

  • The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Restenosis

  • Venous thrombosis

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • Paclitaxel

  • TAXUS

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved